WGS insider trading
HealthcareGeneDx Holdings Corp. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.
Company website: www.genedx.com
WGS insider activity at a glance
FilingIQ has scored 591 insider transactions for WGS since Jul 1, 2022. The most recent filing in our index is dated May 11, 2026.
Across the full history, 49 open-market purchases
and 332 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on WGS insider trades is 62.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest WGS Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading WGS
13F funds holding WGS
Frequently asked
- How many insider trades does FilingIQ track for WGS?
- FilingIQ tracks 591 Form 4 insider transactions for WGS (GeneDx Holdings Corp.), covering filings from Jul 1, 2022 onwards. 83 of those were filed in the last 90 days.
- Are WGS insiders net buyers or net sellers?
- Across the full Form 4 history for WGS, 49 transactions (8%) were open-market purchases and 332 (56%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does WGS insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is WGS in?
- GeneDx Holdings Corp. (WGS) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $2.61B.
Methodology & sources
Every WGS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.